| Announce Date | 12/31/1969 |
| EPS Normalized Actual | $ In Line |
| EPS GAAP Actual | $ In Line |
| Revenue Actual | $0.0488116B |
| Revenue Surprise | Beat by $48.8116M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 425.42 | 425.42 | 0.0488116B | -55.63% | 48.81M |
| FQ4 2020 (Dec 2020) | -36 | -36 | 0.0355388B | 100% | 35.54M |
| FQ1 2024 (Mar 2024) | -1.96 | -1.96 | 0.075966B | -0.16% | 75.97M |
| FQ3 2024 (Sep 2024) | -423.58 | -423.58 | 0.07116B | 100% | 71.16M |
| FQ1 2007 (Jan 2007) | -0.34 | -0.34 | 0B | NAN% | 0M |
| FQ3 2007 (Jul 2007) | -0.34 | -0.34 | 0B | NAN% | 0M |
| FQ4 2007 (Oct 2007) | -0.0982 | -0.0982 | 0B | NAN% | 0M |
| FQ3 2021 (Sep 2021) | -1.52 | -1.52 | 0.0784845B | 100% | 78.48M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2026 (Sep 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ2 2026 (Jun 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 425.42 | 425.42 | 100% | |
| FQ4 2020 (Dec 2020) | -36 | -36 | 100% | |
| FQ1 2024 (Mar 2024) | -1.96 | -1.96 | 100% | |
| FQ3 2024 (Sep 2024) | -423.58 | -423.58 | 100% | |
| FQ1 2007 (Jan 2007) | -0.34 | -0.34 | 100% | |
| FQ3 2007 (Jul 2007) | -0.34 | -0.34 | 100% | |
| FQ4 2007 (Oct 2007) | -0.0982 | -0.0982 | 100% | |
| FQ3 2021 (Sep 2021) | -1.52 | -1.52 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0B | $0.05B | $48.81M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $0.04B | $35.54M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.08B | $75.97M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.07B | $71.16M | 100% |
| FQ1 2007 (Jan 2007) | $0B | $0B | $0M | NAN% |
| FQ3 2007 (Jul 2007) | $0B | $0B | $0M | NAN% |
| FQ4 2007 (Oct 2007) | $0B | $0B | $0M | NAN% |
| FQ3 2021 (Sep 2021) | $0B | $0.08B | $78.48M | 100% |